Double-blind placebo-controlled trial of memantine for treatment of cognitive impairment in patients with Parkinson's disease and dementia.
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Memantine (Primary)
- Indications Dementia; Parkinson's disease
- Focus Therapeutic Use
- 02 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2006 New trial record.